Immunoprecise Antibodies shares owned by UBS Group
Quarter-by-quarter ownership of Immunoprecise Antibodies (IPA) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Immunoprecise Antibodies
Tip: Access up to 7 years of quarterly data
All positions including Immunoprecise Antibodies held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Immunoprecise Antibodies by UBS Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $18k | 11k | 1.71 |
2023-09-30 | $128 | 70 | 1.83 |
2022-12-31 | $8.3k | 1.6k | 5.21 |
2022-09-30 | $0 | 30 | 0.00 |
2022-06-30 | $14k | 3.6k | 3.89 |
2021-12-31 | $21k | 4.0k | 5.27 |
2021-09-30 | $0 | 3.0k | 0.00 |
2021-06-30 | $18k | 3.0k | 6.05 |
2021-03-31 | $12k | 1.2k | 9.74 |